Abstract
An association between primary headaches and attention-deficit/hyperactivity disorder (ADHD) has long been suggested. Moreover, headache is regarded as a common side effect of stimulants, the most effective treatment for ADHD. So far, no systematic review has evaluated the potential association between ADHD and headache. We performed a systematic review of the literature and a meta-analysis of all reported studies on ADHD and primary headaches. Our analysis showed a positive association between ADHD and migraine (OR 1.322, 95% CI 1.018–1717, p value 0.036), but not with tension-type headache. There is a significant association between migraine and ADHD. The mechanisms underlying this association remain to be elucidated, warranting further studies.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Attention-deficit/hyperactivity disorder (ADHD) is one of the most common psychiatric disorders affecting children. Lack of attention, impulsivity, and hyperactivity are the main characteristics of ADHD. Many children with ADHD continue to have dysfunctional symptoms as adults [1, 2]. An estimated 5% of children and 2.5% of adults have ADHD in the United States [3, 4]. ADHD has additionally been linked to other psychiatric disorders [5] and somatic conditions such as asthma and obesity [6].
Headache is a frequent complaint among pediatric age groups [7]. The frequency of headache complaints increases progressively from preschool age to adolescence [8]. The most common causes of primary headaches are tension-type headache (TTH) and migraine. The prevalence of migraine, for instance, increases throughout childhood, affecting 1–3% of 3–7-year-old children, 4–11% of 7–11-year-old kids, and 8–28% of teenagers between 13 and 18 years old [9]. It ranges between 16.6 and 22.7% among adults older than 18, with higher prevalence among females (25%) compared to males (11%) [10].
According to hospital-based studies, children with headaches and ADHD have a significant lower quality-of-life scores compared to healthy children [11, 12], as well as higher incidence of other psychiatric disorders. Interestingly, stimulants—the main and most effective pharmacological treatment for ADHD—are reported to induce headache among other side effects [13]. Whether drug induced or not, headache is a common complaint among children with ADHD [14, 15]. It is imperative to assess the strength of the association between ADHD and primary headaches to elucidate possible common pathophysiological pathways, and also to guide treatment.
In this review, we carried out a systematic review of the literature to determine whether there is comorbidity/association between ADHD and primary headaches. In addition, we performed a meta-analysis of the available data.
Methods
Three independent literature searches using the keywords “ADHD”, “Headache”, “Migraine”, and “Tension-Type Headache” were performed. The electronic databases PubMed, ScienceDirect, Google Scholar, and PsycINFO were searched for all published data from January 2000 till January 2017. The specific number of all retrieved, included, and excluded articles at each step of our literature search is provided in Fig. 1, built according to the PRISMA guidelines.
Inclusion criteria
Studies evaluating the comorbidity between migraine, TTH, and ADHD in adults or adolescents were included. ADHD was defined according to ICD-9, 10 or DSM-III, -IV criteria [16, 17]. Different protocols were used to classify individuals as having ADHD: (a) ADHD clinically diagnosed based on the use of semi-structured interviews; (b) ADHD medication use as a proxy for ADHD diagnosis; (c) symptoms of ADHD measured by a validated ADHD symptom rating scale; (d) information on ADHD cases from clinical databases. Peer-reviewed studies published in English, French, Spanish, Portuguese, German, Arabic, and Chinese were included, as those are the languages fluently spoken by the authors of this review. All the studies that classified headache into subtypes (Migraine, TTH) according to the International Classification of Headache Disorders (ICHD) criteria were included [18].
Exclusion criteria
The following exclusion criteria were applied: (a) studies not including ADHD as described under inclusion criteria; (b) case reports, communications, opinions, and expert reviews; (c) publications not subjected to peer review; (d) studies with incomplete or unreported data; (e) pharmacological trials focusing on specific treatment options and not on comorbid disorders; (f) studies on traumatic events, as we consider these to be outside the main focus of this review; (g) studies in any other language than those mentioned in the inclusion criteria; and (h) studies that could not be fully retrieved.
Study quality and data analysis
Data were qualified according to the study quality form of the “Guide to Community Preventive Services” [19, 20]. The form has six categories of data classification. These categories are related to potential study problems that can limit the ability to interpret the results, for example, descriptions of the study population or intervention, sampling, measurement, analysis, interpretation of results, and other limitations. After summation of the limitations’ number in each category, each study was then scored per the scoring criteria. A study with 0–1 limitation was rated as good execution quality; 2–4 limitations as fair execution quality; and five or more limitations as limited execution quality. In addition, we extracted publication year, study design, assessment tools, geographic location, and demographic data (Table 1).
The meta-analysis was done with three different settings, using comprehensive meta-analysis Version 3 licensed software (http://www.meta-analysis.com). Continuous data from eligible studies were analyzed, and due to the heterogeneity in rating scales and indices measures reported by different studies, a two-sided random effect model of meta-analysis was applied. Tests for overall effect sizes (Z), odds ratios (OR) for associations with their 95% confidence intervals (95% CI), and p values were performed. p values less than or equal 0.05 in a confidence interval of 95% were considered significant.
Results
Search results
Of the 102 hits in the initial search, 84 records remained after duplicates were removed, from which 24 titles were deemed irrelevant after screening. The remaining 59 abstracts were screened for title/abstract and 35 of them were irrelevant to the topic. The full text of 24 articles was read. Ten manuscripts were not eligible (one was in Polish, two did not report data results, one was a case report, and six were reviews), while 14 original articles fulfilled all the inclusion criteria (Fig. 1; Table 1).
Review of the study designs of the included articles
All included studies (n = 14) are summarized in Table 1. The studies included 43,244 participants with the exception of one study [21] that included the full national registry of the Norwegian population (n = 4,640,219). Most studies (n = 12) included only adolescents, one study included an adult only sample [22], and one study included an all population registry [21].
Nine studies (64%) used a cross-sectional design. Three studies used a retrospective analysis [23,24,25], and only two studies did a prospective evaluation [26, 27]. Eight studies (57%) had more males than females, while five (35.7%) of them included more females. One study did not report the numbers of male and female populations [28]. Twelve studies included control groups, while two studies lacked a control group [21, 24].
Methods of ADHD assessment in the studies
Ten studies (71.4%) used direct face-to-face interviews with different assessment tools for the diagnosis of ADHD based upon DSM-IV criteria (Table 1). The rest of the studies (n = 4) did not use direct interviews. One study used a self-administered computer-based assessment questionnaire for the diagnosis of ADHD [27], two studies relied on the information extracted from national data registries on previous diagnosis of ADHD [28, 29], and one study used the national prescription registry of ADHD medications as a proxy for ADHD diagnosis [21].
Methods of headache assessment in the studies
Ten studies (71.4%) used the ICHD for the diagnosis of headache among their sample (Table 1). Three studies (21.4%) relied on patient/parent self-reports of primary headache [22, 28, 30]. One study used a national prescription registry of anti-migraine medications as a proxy for migraine diagnosis [21].
Eight studies (57.1%) evaluated migraine—as a clearly diagnosed headache subtype by ICHD criteria—in relation to ADHD (Fig. 3) [22, 23, 25, 27, 31,32,33,34].
Five studies (35.7%) evaluated TTH—as a clearly diagnosed headache subtype by the ICHD criteria—in relation to ADHD (Fig. 4) [23, 25, 32,33,34].
Methodological considerations and limitations of the studies
Several limitations were identified in each 1 of the 14 studies under review. Apart from the heterogeneity of the diagnostic techniques and samples used, one of the main overall limitations was that 57.1% of the studies (n = 8) focused on the association between ADHD and headache, while 42.9% of the studies (n = 6) did not focus merely on this association but also investigated other comorbidities which could potentially be a source of confounding bias.
The absence of control groups was another major limitation in two studies [21, 24]. The absence of detailed results in one study was considered a limitation [26]. Relying on patient/parent subjective reports for the clinical diagnosis of headaches was another limitation in three studies [22, 28, 30].
Moreover, using medication databases as a proxy for ADHD and migraine diagnoses [21] is also prone to considerable bias; the traditional medications for ADHD and migraine may have been prescribed for other conditions; and self-medication, with over-the-counter analgesics, could be present.
Interestingly, most studies ignored the reports that linked stimulants to headache as a side effect and those that concluded that patients treated with stimulants for ADHD might develop headache as a medication side effect and not have it a comorbid condition [35, 36].
A technology consideration also arises from entirely depending on computer-based surveys for a diagnosis of ADHD. One of the studies had a significant discrepancy in results [27], thus raising concerns about the validity of computer-based questionnaire techniques.
Remarkably, most of the published data resulted from cross-sectional (n = 9) and retrospective studies (n = 3), rendering it difficult to infer the causality between headaches and ADHD. Only two studies had a prospective design, with only one cohort study among them [27]. This can be attributed to the higher cost of conducting cohorts. Accordingly, there is still a need for these types of studies.
Meta-analysis
Data from 11 studies were used for meta-analysis. Three studies were not included in the analysis as two articles lacked a control group, and one article did not report its full data as per inclusion criteria (Table 1).
Not all studies identified headache subtypes, i.e., migraine or TTH. Migraine was fully defined in 8 studies and TTH in only 5 out of the 11 studies.
Accordingly, we categorized our data for analysis in three strata. In the first-level stratification, we used all studies (n = 11) as a general headache reference and analyzed them together. The first-level results showed a non-significant association between headache, in general, and ADHD (OR 1.009, 95% CI 0.501–2.034, p value 0.980) (Fig. 2). In the second-level analysis, we used the studies diagnosing migraine (n = 8), revealing a significant positive association between migraine and ADHD (OR 1.322, 95% CI 1.018–1717, p value 0.036) (Fig. 3). In the third-level analysis, we used the studies diagnosing TTH (n = 5) that showed a non-significant association between TTH and ADHD (OR 1.068, 95% CI 0.994–1.312, p value 0.679) (Fig. 4).
Discussion
To our knowledge, this is the first systematic review and meta-analysis evaluating the association between ADHD and headache. Historically, Leviton was one of the first authors to report that out of 150 elementary-school children who were referred to his clinic for recurrent headaches; approximately 40% of them had academic difficulties [37]. His results came in accordance with later studies that reported a higher incidence of hyperactivity and impulsivity symptoms in children with headache in comparison to healthy peers [38, 39].
Several studies have demonstrated an association between ADHD and several other comorbidities [40,41,42,43,44,45,46]. However, the specific association between ADHD and headache remained debatable. In our current systematic review and meta-analysis, the data provide compelling evidence of an association between ADHD and migraine.
During the past 2 decades, few studies have focused on ADHD with headache as a comorbidity. Most of the studies included in our review reported a positive association between ADHD and headache, while a few did not report any association [25, 26, 33]. The variability of results can be attributed to several factors, including discrepancy in diagnostic protocols, non-representative samples, and heterogeneity of assessment tools.
The causal relationship between ADHD and migraine could not be determined, since most currently available studies are cross-sectional. However, some authors tried to speculate that a relationship between ADHD and migraine emerges from a common underlying pathophysiology. For instance, Villa and colleagues described impaired visual attention in children with migraine and suggested that this is dependent on neurotransmitters such as dopamine and noradrenalin. Such neurotransmitters are also involved in the pathophysiology of migraine, thus suggesting that this might predispose those children to attention deficit [47]. Other neurotransmitters such as GABA are also implicated in the pathophysiology of both conditions [48,49,50]. A different hypothesis was that frequent headaches independently increase distractibility and irritation especially in children with a primary short attention span, thus imposing a further burden on the challenge of learning. This is supported by a study that found a correlation between neuropsychological deficits and frequency of headache episodes [51]. Moreover, a genetic background theory was hypothesized based on a genome-wide analysis study [52].
ADHD is associated with other conditions with a strong genetic component. For instance, epilepsy [53,54,55,56] and vasovagal syncope [57,58,59] are commonly comorbid with migraine. However, we have not identified any meta-analyses confirming the association between ADHD and epilepsy or ADHD and vasovagal syncope. Further studies should take into consideration that the genetic and pathologic underpinnings of these heterogeneous syndromes may overlap, promoting a better understanding of common neural pathways. As an example, structural and functional abnormalities in corticosubcortical brain networks found to be central in both migraine and ADHD pathophysiology [60, 61] also play an important role in obesity. Obesity is also associated with cognitive problems leading to decline in intellectual performance [62,63,64], which can be mistaken as ADHD. This is particularly important when obesity in children has become an epidemic. Another area that should be explored further is the cognitive profile of children affected by headaches/migraine. Cognitive abilities, particularly verbal skills, reaction time, and information speed processing may be impaired in children with headaches [65, 66]. We hope that these findings are quickly incorporated into the clinical assessment of patients with ADHD.
Finally, as supported by recent results, the adverse effects of stimulants could be a causative factor for the complaint of headaches among patients with ADHD [67,68,69,70]. Data from randomized clinical trials on methylphenidate support at least in part this assumption [71,72,73,74]. On the other hand, Genizi and colleagues found no difference in headache prevalence rates among students with ADHD who took medications such as methylphenidate and those who were not taking medications for ADHD [27].
Conclusion
In this manuscript, we provided a comprehensive review together with a meta-analysis of the available data on the association between headache and ADHD. Our results confirmed that there is a significant association between migraine and ADHD. However, the pathogenesis of such an association remains unknown to date, warranting further studies.
References
Moffitt TE, Houts R, Asherson P et al (2015) Is adult ADHD a childhood-onset neurodevelopmental disorder? Evidence from a four-decade longitudinal cohort study. Am J Psychiatry 172(10):967–977. doi:10.1176/appi.ajp.2015.14101266
Caye A, Rocha TB, Anselmi L et al (2016) Attention-deficit/hyperactivity disorder trajectories from childhood to young adulthood: evidence from a birth cohort supporting a late-onset syndrome. JAMA Psychiatry 73(7):705–712. doi:10.1001/jamapsychiatry.2016.0383
Garner AA, O’Connor BC, Narad ME et al (2013) The relationship between ADHD symptom dimensions, clinical correlates, and functional impairments. J Dev Behav Pediatr 34(7):469–477
Saylor KE, Amann BH (2016) Impulsive aggression as a comorbidity of attention-deficit/hyperactivity disorder in children and adolescents. J Child Adolesc Psychopharmacol 26(1):19–25. doi:10.1089/cap.2015.0126
Halmøy A, Fasmer OB, Gillberg C et al (2009) Occupational outcome in adult ADHD: impact of symptom profile, comorbid psychiatric problems and treatment: a cross sectional study of 414 clinically diagnosed adult ADHD patients. J Atten Disord 13:75–87
Cortese S, Angriman M, Maffeis C et al (2008) Attention-deficit/hyperactivity disorder (ADHD) and obesity: a systematic review of the literature. Crit Rev Food Sci Nutr 48:524–537
Ozge A, Sasmaz T, Cakmak SE et al (2010) Epidemiological-based childhood headache natural history study: after an interval of six years. Cephalalgia 30:703–712
Gunner KB, Smith HD (2007) Practice guideline for diagnosis and management of migraine headaches in children and adolescents: part one. J Pediatr Health Care 21:327–332
Oakley CB, Kossoff EH (2014) Migraine and epilepsy in pediatric population. Curr Pain Headache Rep 18(3):402. doi:10.1007/s11916-013-0402-3
Smitherman TA, Burch R, Sheikh H et al (2013) The prevalence, impact, and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies. Headache 53(3):427–436. doi:10.1111/head.12074
Agarwal R, Goldenberg M, Perry R et al (2012) The quality of life of adults with attention deficit hyperactivity disorder: a systematic review. Innov Clin Neurosci 9(5–6):10–21
Instanes JT, Klungsoyr K, Halmoy A, et al. Adult ADHD and comorbid somatic disease: a systematic literature review. J Atten Disord. 2016. doi:10.1177/1087054716669589
Zeni CP, Guimarães AP, Polanczyk GV et al (2007) No significant association between response to methylphenidate and genes of the dopaminergic and serotonergic systems in a sample of Brazilian children with attention-deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 144B(3):391–394
Albers L, von Kries R, Heinen F et al (2015) Headache in school children: Is the prevalence increasing? Curr Pain Headache Rep 19:4. doi:10.1007/s11916015-0477-0
Mahajnah M, Sharkia R, Shorbaji N et al (2017) The clinical characteristics of ADHD diagnosed in adolescents in comparison with younger children. J Atten Disord 1:1087054717696768. doi:10.1177/1087054717696768
American Psychiatric Association (1980) Diagnostic and statistical manual of mental disorders, 3rd edn. APA, Washington, DC
American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, 4th edn. APA, Washington, DC
Headache Classification Committee of the International Headache Society (2004) The international classification of headache disorders: 2nd edition. Cephalalgia 24(Suppl. 1):9–160
Truman BI, Smith-Akin CK, Hinman AR et al (2000) Developing the Guide to Community Preventive Services—overview and rationale. The Task Force on Community Preventive Services. Am J Prev Med 18(1 Suppl):18–26
Briss PA, Brownson RC, Fielding JE et al (2004) Developing and using the Guide to Community Preventive Services: lessons learned about evidence-based public health. Annu Rev Public Health 25:281–302
Fasmer OB, Riise T, Lund A et al (2012) Comorbidity of migraine with ADHD. J Atten Disord 16(4):339–345. doi:10.1177/1087054710385784
Fasmer OB, Halmoy A, Oedegaard KJ et al (2011) Adult attention deficit hyperactivity disorder is associated with migraine headaches. Eur Arch Psychiatry Clin Neurosci 261(8):595–602. doi:10.1007/s00406-011-0203-9
Arruda MA, Arruda R (2014) Psychological adjustment in children with episodic migraine: a population-based study. Psychol Neurosci 7:33–41. doi:10.3922/j.psns.2014.1.06
Genizi J, Gordon S, Kerem NC et al (2013) Primary headaches, attention deficit disorder and learning disabilities in children and adolescents. J Headache Pain 14:54. doi:10.1186/1129-2377-14-54
Pavone P, Rizzo R, Conti I et al (2012) Primary headaches in children: clinical findings on the association with other conditions. Int J Immunopathol Pharmacol 25(4):1083–1091
Riva D, Usilla A, Aggio F et al (2012) Attention in children and adolescents with headache. Headache 52(3):374–384. doi:10.1111/j.1526-4610.2011.02033.x
Genizi J, Marom D, Srugo I, et al. The relations between attention deficit hyperactivity disorder and headaches in a non-clinical sample of adolescents. Acad J Ped Neonatolo. 2016;2(2):AJPN.MS.ID.555583
Strine TW, Okoro CA, McGuire LC et al (2006) The associations among childhood headaches, emotional and behavioral difficulties, and health care use. Pediatrics 117(5):1728–1735
Lateef TM, Merikangas KR, He J et al (2009) Headache in a national sample of american children: prevalence and comorbidity. J Child Neurol 24(5):536–543. doi:10.1177/0883073808327831
Pitrou I, Shojaei T, Chan-Chee C et al (2010) The associations between headache and psychopathology: a survey in school children. Headache 50:1537–1548. doi:10.1111/j.1526-4610.2010.01781.x
Jameson ND, Sheppard BK, Lateef T et al (2016) Medical comorbidity of attention-deficit/hyperactivity disorder in US adolescents. J Child Neurol 31(11):1282–1289
Arruda MA, Bigal ME (2012) Migraine and migraine subtypes in preadolescent children: association with school performance. Neurology 79(18):1881–1888. doi:10.1212/WNL.0b013e318271f812
Arruda MA, Guidetti V, Galli F et al (2010) Migraine, tension-type headache, and attention-deficit/hyperactivity disorder in childhood: a population-based study. Postgrad Med 122(5):18–26. doi:10.3810/pgm.2010.09.2197
Mazzone L, Vitiello B, Incorpora G et al (2006) Behavioural and temperamental characteristics of children and adolescents suffering from primary headache. Cephalalgia 26(2):194–201
Reddy DS (2013) Current pharmacotherapy of attention deficit hyperactivity disorder. Drugs Today (Barc) 49(10):647–665. doi:10.1358/dot.2013.49.10.2008996
Clavenna A, Bonati M (2014) Safety of medicines used for ADHD in children: a review of published prospective clinical trials. Arch Dis Child 99(9):866–872. doi:10.1136/archdischild-2013-304170
Leviton A (1986) Do learning handicaps and headache cluster? J Child Neurol 1:372–377
Calandre EP, Bembibre J, Arnedo ML et al (2002) Cognitive disturbances and regional cerebral blood flow abnormalities in migraine patients: their relationship with the clinical manifestations of the illness. Cephalalgia 22:291–302
Bellini B, Arruda M, Cescut A et al (2013) Headache and comorbidity in children and adolescents. J Headache Pain 14(1):79. doi:10.1186/1129-2377-14-79
Gümüş YY, Çakin Memik N, Ağaoğlu B (2015) Anxiety disorders comorbidity in children and adolescents with attention deficit hyperactivity disorder. Noro Psikiyatr Ars 52(2):185–193. doi:10.5152/npa.2015.7024
Eyre O, Langley K, Stringaris A et al (2017) Irritability in ADHD: associations with depression liability. J Affect Disord 25(215):281–287. doi:10.1016/j.jad.2017.03.050
Özdemir O, Boysan M, Güzel Özdemir P et al (2015) Relations between post-traumatic stress disorder, dissociation and attention deficit/hyperactivity disorder among earthquake survivors. Noro Psikiyatr Ars 52(3):252–257. doi:10.5152/npa.2015.7616
Berkol TD, Yargiç İ, Özyildirim İ et al (2014) Comorbidity of adult attention deficit and hyperactivity disorder in bipolar patients: prevalence, sociodemographic and clinical correlates. Noro Psikiyatr Ars 51(2):97–102. doi:10.4274/npa.y6376
Son YD, Han DH, Kim SM et al (2017) A functional connectivity comparison between attention deficit hyperactivity disorder and bipolar disorder in medication-naïve adolescents with mood fluctuation and attention problems. Psychiatry Res 17(263):1–7. doi:10.1016/j.pscychresns.2017.02.006
McGough JJ, Smalley SL, McCracken JT et al (2005) Psychiatric comorbidity in adult attention deficit hyperactivity disorder: findings from multiplex families. Am J Psychiatry 162(9):1621–1627
Kessler RC, Adler L, Barkley R et al (2006) The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 163(4):716–723
Villa TR, Correa Moutran AR, Sobirai Diaz LA et al (2009) Visual attention in children with migraine: a controlled comparative study. Cephalalgia 29:631–634. doi:10.1111/j.1468-2982.2008.01767.x
Biederman J, Ball SW, Monuteaux MC et al (2008) New insights into the comorbidity between ADHD and major depression in adolescent and young adult females. J Am Acad Child Adolesc Psychiatry 47(4):426–434
Edden RAE, Crocetti D, Zhu H et al (2012) Reduced GABA concentration in attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 69(7):750–753
Naaijen J, Bralten J, Poelmans G et al (2017) Glutamatergic and GABAergic gene sets in attention-deficit/hyperactivity disorder: association to overlapping traits in ADHD and autism. Transl Psychiatry 7(1):e999. doi:10.1038/tp.2016.273
Camarda C, Monastero R, Pipia C et al (2007) Interictal executive disfunction in migraineurs without aura: relationship with duration and intensity o attacks. Cephalalgia 27:1094–1110
Williams NM, Zaharieva I, Martin A et al (2010) Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis. Lancet 376(9750):1401–1408. doi:10.1016/S0140-6736(10)61109-9
Kattimani S, Mahadevan S (2011) Treating children with attention-deficit/hyperactivity disorder and comorbid epilepsy. Ann Indian Acad Neurol 14(1):9–11. doi:10.4103/0972-2327.78042
Kim EH, Yum MS, Kim HW, Ko TS (2014) Attention-deficit/hyperactivity disorder and attention impairment in children with benign childhood epilepsy with centrotemporal spikes. Epilepsy Behav 37:54–58. doi:10.1016/j.yebeh.2014.05.030
Kanemura H, Sano F, Ishii S, Ohyama T, Sugita K, Aihara M (2013) Characteristics of headache in childer with epilepsy. Seizure 22(8):647–650
Papetti L, Nicita F, Parisi P, Spalice A, Villa MP, Trenite DGAK (2013) Headache and epilepsy—how are they connected? Epilepsy Behav 26(3):386–393
Zhang C, Kutyifa V, Moss AJ, McNitt S, Zareba W, Kaufman ES (2015) Long-QT syndrome and therapy for attention deficit/hyperactivity disorder. J Cardiovasc Electrophysiol 26(10):1039–1044. doi:10.1111/jce.12739
Paisley RD, Arora HS, Nazeri A, Massumi A, Razavi M (2009) Migraine and vasodepressor syncope in a large family. Tex Heart Inst J 36(5):468–469
Curfman D, Chilungu M, Daroff RB, Alshekhlee A, Chelimsky G, Chelimsky TC (2012) Syncopal migraine. Clin Auton Res 22(1):17–23. doi:10.1007/s10286-011-0141-7
Parisi P, Verrotti A, Paolino MC, Ferretti A, Raucci U, Moavero R, Villa MP, Curatolo P (2014) Headache and attention deficit and hyperactivity disorder in children: common condition with complex relation and disabling consequences. Epilepsy Behav 32:725
Paolino MC, Ferretti A, Villa MP, Parisi P (2015) Headache and ADHD in pediatric age: possible physiopathological links. Curr Pain Headache Rep 19(7):25
Parisi P, Verrotti A, Paolino MC, Miano S, Urbano A, Bernabucci M, Villa MP (2010) Cognitive profile, parental education and BMI in children: reflections on common neuroendrocrinobiological roots. Pediatr Endocrinol Metab 23(11):113341
Nguyen JCD, Killcross AS, Jenkins TA (2014) Obesity and cognitive decline: role of inflammation and vascular changes. Front Neurosci 8:375. doi:10.3389/fnins.2014.00375
Wang C, Chan JSY, Ren L, Yan JH (2016) Obesity reduces cognitive and motor functions across the lifespan. Neural Plast 2016:2473081. doi:10.1155/2016/2473081
Parisi P, Verrotti A, Paolino MC, Urbano A, Bernabucci M, Castaldo R, Villa MP (2010) Headache and cognitive profile in children: a crosssectional controlled study. J Headache Pain 11(1):4551
Moutran ARC, Villa TR, Diaz LAS, Noffs MHS, Pinto MMP; Gabbai AA; Carvalho DS. Migraine and cognition in children: a controlled study. Arq Neuro Psiquiatr. 2011. doi:10.1590/S0004-282X2011000200010. (São Paulo)
Ozbaran B, Kose S, Yuzuguldu O et al (2015) Combined methylphenidate and atomoxetine pharmacotherapy in attention deficit hyperactivity disorder. World J Biol Psychiatry 16(8):619–624. doi:10.3109/15622975.2015.1051109
Tenore GC, Daglia M, Orlando V et al (2015) Coffee and depression: a short review of literature. Curr Pharm Des 21(34):5034–5040
Lee MJ, Choi HA, Choi H et al (2016) Caffeine discontinuation improves acute migraine treatment: a prospective clinic-based study. J Headache Pain 17(1):71. doi:10.1186/s10194-016-0662-5
Stark JG, Engelking D, McMahen R et al (2016) A randomized crossover study to assess the pharmacokinetics of a novel amphetamine extended-release orally disintegrating tablet in healthy adults. Postgrad Med 128(7):648–655. doi:10.1080/00325481.2016.1216716
Ames D, Carr-Lopez SM, Gutierrez MA et al (2016) Detecting and managing adverse effects of antipsychotic medications: current state of play. Psychiatr Clin N Am 39(2):275–311. doi:10.1016/j.psc.2016.01.008
Schrantee A, Tamminga HGH, Bouziane C et al (2016) Age-dependent effects of methylphenidate on the human dopaminergic system in young vs adult patients with attention-deficit/hyperactivity disorder. JAMA Psychiatry 73(9):955–962. doi:10.1001/jamapsychiatry.2016.1572
Schrantee A, Bouziane C, Bron EE et al (2017) Long-term effects of stimulant exposure on cerebral blood flow response to methylphenidate and behavior in attention-deficit hyperactivity disorder. Brain Imaging Behav. doi:10.1007/s11682-017-9707-x
Kral MC, Lally MD, Boan AD (2017) Effectiveness and side effect profile of stimulant medication for the treatment of attention-deficit/hyperactivity disorder in youth with epilepsy. J Child Adolesc Psychopharmacol. doi:10.1089/cap.2016.0186
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interests
The authors declare that they have no conflict of interests associated and that no funding of any kind is associated with this work.
Rights and permissions
About this article
Cite this article
Salem, H., Vivas, D., Cao, F. et al. ADHD is associated with migraine: a systematic review and meta-analysis. Eur Child Adolesc Psychiatry 27, 267–277 (2018). https://doi.org/10.1007/s00787-017-1045-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00787-017-1045-4